O	0	10	Expression	Expression	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	29	osteoprotegerin	osteoprotegerin	NN	B-NP
O	30	33	and	and	CC	I-NP
O	34	38	RANK	RANK	NN	I-NP
O	39	45	ligand	ligand	NN	I-NP
O	46	48	in	in	IN	B-PP
B-Cancer	49	55	breast	breast	NN	B-NP
I-Cancer	56	62	cancer	cancer	NN	I-NP
B-Tissue	63	67	bone	bone	NN	I-NP
O	68	78	metastasis	metastasis	NN	I-NP
O	78	79	.	.	.	O

B-Tissue	81	85	Bone	Bone	NN	B-NP
O	86	97	destruction	destruction	NN	I-NP
O	98	100	is	be	VBZ	B-VP
O	101	110	primarily	primarily	RB	I-VP
O	111	119	mediated	mediate	VBN	I-VP
O	120	122	by	by	IN	B-PP
B-Cell	123	135	osteoclastic	osteoclastic	JJ	B-NP
B-Tissue	136	140	bone	bone	NN	I-NP
O	141	151	resorption	resorption	NN	I-NP
O	151	152	,	,	,	O
O	153	156	and	and	CC	O
B-Cell	157	163	cancer	cancer	NN	B-NP
I-Cell	164	169	cells	cell	NNS	I-NP
O	170	179	stimulate	stimulate	VBP	B-VP
O	180	183	the	the	DT	B-NP
O	184	193	formation	formation	NN	I-NP
O	194	197	and	and	CC	I-NP
O	198	208	activation	activation	NN	I-NP
O	209	211	of	of	IN	B-PP
B-Cell	212	223	osteoclasts	osteoclast	NNS	B-NP
O	224	228	next	next	JJ	B-VP
O	229	231	to	to	TO	B-PP
B-Cancer	232	242	metastatic	metastatic	JJ	B-NP
I-Cancer	243	247	foci	focus	NNS	I-NP
O	247	248	.	.	.	O

O	249	261	Accumulating	Accumulate	VBG	B-NP
O	262	271	evidences	evidence	NNS	I-NP
O	272	280	indicate	indicate	VBP	B-VP
O	281	285	that	that	IN	B-SBAR
O	286	294	receptor	receptor	NN	B-NP
O	295	304	activator	activator	NN	I-NP
O	305	307	of	of	IN	B-PP
O	308	310	NF	NF	NN	B-NP
O	310	311	-	-	HYPH	O
O	311	313	kB	kB	NN	B-NP
O	314	320	ligand	ligand	NN	I-NP
O	321	322	(	(	(	O
O	322	327	RANKL	RANKL	NN	B-NP
O	327	328	)	)	)	O
O	329	331	is	be	VBZ	B-VP
O	332	335	the	the	DT	B-NP
O	336	344	ultimate	ultimate	JJ	I-NP
B-Immaterial_anatomical_entity	345	358	extracellular	extracellular	JJ	I-NP
O	359	367	mediator	mediator	NN	I-NP
O	368	372	that	that	WDT	B-NP
O	373	383	stimulates	stimulate	VBZ	B-VP
B-Cell	384	394	osteoclast	osteoclast	NN	B-NP
O	395	410	differentiation	differentiation	NN	I-NP
O	411	415	into	into	IN	B-PP
O	416	422	mature	mature	JJ	B-NP
B-Cell	423	434	osteoclasts	osteoclast	NNS	I-NP
O	434	435	.	.	.	O

O	436	438	In	In	IN	B-PP
O	439	447	contrast	contrast	NN	B-NP
O	447	448	,	,	,	O
O	449	464	osteoprotegerin	osteoprotegerin	NN	B-NP
O	465	466	(	(	(	O
O	466	469	OPG	OPG	NN	B-NP
O	469	470	)	)	)	O
O	471	479	inhibits	inhibit	VBZ	B-VP
B-Cell	480	490	osteoclast	osteoclast	NN	B-NP
O	491	502	development	development	NN	I-NP
O	502	503	.	.	.	O

O	504	506	In	In	IN	B-SBAR
O	507	512	order	order	NN	O
O	513	515	to	to	TO	B-VP
O	516	525	elucidate	elucidate	VB	I-VP
O	526	527	a	a	DT	B-NP
O	528	537	mechanism	mechanism	NN	I-NP
O	538	541	for	for	IN	B-PP
B-Cancer	542	548	cancer	cancer	NN	B-NP
O	548	549	-	-	HYPH	B-NP
O	549	556	induced	induce	VBN	I-NP
O	557	575	osteoclastogenesis	osteoclastogenesis	NN	I-NP
O	575	576	,	,	,	O
B-Cell	577	582	cells	cell	NNS	B-NP
O	583	587	from	from	IN	B-PP
O	588	589	a	a	DT	B-NP
O	590	595	human	human	JJ	I-NP
B-Cell	596	602	breast	breast	NN	I-NP
I-Cell	603	609	cancer	cancer	NN	I-NP
I-Cell	610	614	line	line	NN	I-NP
O	614	615	,	,	,	O
B-Cell	616	619	MDA	MDA	NN	B-NP
I-Cell	619	620	-	-	HYPH	B-NP
I-Cell	620	622	MB	MB	NN	I-NP
I-Cell	622	623	-	-	HYPH	B-NP
I-Cell	623	626	231	231	CD	I-NP
O	626	627	,	,	,	O
O	628	632	were	be	VBD	B-VP
O	633	641	directly	directly	RB	B-ADVP
O	642	644	co	co	AFX	O
O	644	645	-	-	HYPH	O
O	645	653	cultured	culture	VBN	B-VP
O	654	658	with	with	IN	B-PP
B-Cell	659	662	ST2	ST2	NN	B-NP
O	662	663	,	,	,	O
B-Cell	664	669	MC3T3	MC3T3	NN	B-NP
I-Cell	669	670	-	-	HYPH	B-NP
I-Cell	670	672	E1	E1	NN	I-NP
O	672	673	,	,	,	O
O	674	676	or	or	CC	O
O	677	681	with	with	IN	B-PP
O	682	689	primary	primary	JJ	B-NP
O	690	695	mouse	mouse	NN	I-NP
B-Cell	696	705	calvarial	calvarial	JJ	I-NP
I-Cell	706	711	cells	cell	NNS	I-NP
O	711	712	.	.	.	O

B-Cell	713	723	Osteoclast	Osteoclast	NN	B-NP
I-Cell	723	724	-	-	HYPH	I-NP
I-Cell	724	728	like	like	JJ	I-NP
I-Cell	729	734	cells	cell	NNS	I-NP
O	735	738	and	and	CC	O
O	739	748	tartarate	tartarate	JJ	B-NP
O	749	758	resistant	resistant	JJ	I-NP
O	759	763	acid	acid	NN	I-NP
O	764	775	phosphatase	phosphatase	NN	I-NP
O	776	777	(	(	(	O
O	777	781	TRAP	TRAP	NN	B-NP
O	781	782	)	)	)	O
O	783	793	activities	activity	NNS	B-NP
O	794	798	were	be	VBD	B-VP
O	799	803	then	then	RB	I-VP
O	804	815	quantitated	quantitate	VBN	I-VP
O	815	816	.	.	.	O

O	817	819	We	We	PRP	B-NP
O	820	828	examined	examine	VBD	B-VP
O	829	834	these	these	DT	B-NP
B-Cell	835	839	cell	cell	NN	I-NP
I-Cell	840	845	lines	line	NNS	I-NP
O	846	849	and	and	CC	O
B-Cancer	850	857	samples	sample	NNS	B-NP
O	858	862	from	from	IN	B-PP
B-Cancer	863	869	breast	breast	NN	B-NP
I-Cancer	870	876	cancer	cancer	NN	I-NP
O	877	879	by	by	IN	B-PP
O	880	882	RT	RT	NN	B-NP
O	882	883	-	-	HYPH	B-NP
O	883	886	PCR	PCR	NN	I-NP
O	887	890	for	for	IN	B-PP
O	891	894	the	the	DT	B-NP
O	895	906	expressions	expression	NNS	I-NP
O	907	909	of	of	IN	B-PP
O	910	913	OPG	OPG	NN	B-NP
O	914	917	and	and	CC	I-NP
O	918	923	RANKL	RANKL	NN	I-NP
O	924	928	mRNA	mRNA	NN	I-NP
O	928	929	.	.	.	O

O	930	938	Compared	Compare	VBN	B-PP
O	939	941	to	to	TO	B-PP
O	942	950	controls	control	NNS	B-NP
O	950	951	,	,	,	O
O	952	954	co	co	AFX	O
O	954	955	-	-	HYPH	O
O	955	962	culture	culture	NN	B-NP
O	963	965	of	of	IN	B-PP
B-Cell	966	969	MDA	MDA	NN	B-NP
I-Cell	969	970	-	-	HYPH	B-NP
I-Cell	970	972	MB	MB	NN	I-NP
I-Cell	972	973	-	-	HYPH	O
I-Cell	973	976	231	231	CD	B-NP
I-Cell	977	982	cells	cell	NNS	I-NP
O	983	987	with	with	IN	B-PP
B-Cell	988	995	stromal	stromal	JJ	B-NP
O	996	998	or	or	CC	I-NP
B-Cell	999	1011	osteoblastic	osteoblastic	JJ	I-NP
I-Cell	1012	1017	cells	cell	NNS	I-NP
O	1018	1025	induced	induce	VBD	B-VP
O	1026	1028	an	an	DT	B-NP
O	1029	1037	increase	increase	NN	I-NP
O	1038	1040	in	in	IN	B-PP
O	1041	1047	number	number	NN	B-NP
O	1048	1050	of	of	IN	B-PP
B-Cell	1051	1062	osteoclasts	osteoclast	NNS	B-NP
O	1063	1066	and	and	CC	O
O	1067	1071	TRAP	TRAP	NN	B-NP
O	1072	1082	activities	activity	NNS	I-NP
O	1082	1083	.	.	.	O

B-Cell	1084	1087	MDA	MDA	NN	B-NP
I-Cell	1087	1088	-	-	HYPH	I-NP
I-Cell	1088	1090	MB	MB	NN	I-NP
I-Cell	1090	1091	-	-	HYPH	O
I-Cell	1091	1094	231	231	CD	B-NP
I-Cell	1095	1100	cells	cell	NNS	I-NP
O	1101	1106	alone	alone	RB	B-ADVP
O	1107	1109	or	or	CC	O
B-Cancer	1110	1116	breast	breast	NN	B-NP
I-Cancer	1117	1123	cancer	cancer	NN	I-NP
I-Cancer	1124	1131	samples	sample	NNS	I-NP
O	1132	1135	did	do	VBD	B-VP
O	1136	1139	not	not	RB	I-VP
O	1140	1147	express	express	VB	I-VP
O	1148	1153	RANKL	RANKL	NN	B-NP
O	1154	1158	mRNA	mRNA	NN	I-NP
O	1158	1159	.	.	.	O

O	1160	1167	However	However	RB	B-ADVP
O	1167	1168	,	,	,	O
O	1169	1171	co	co	AFX	B-NP
O	1171	1172	-	-	HYPH	I-NP
O	1172	1179	culture	culture	NN	I-NP
O	1180	1182	of	of	IN	B-PP
O	1183	1188	these	these	DT	B-NP
B-Cell	1189	1195	cancer	cancer	NN	I-NP
I-Cell	1196	1201	cells	cell	NNS	I-NP
O	1202	1206	with	with	IN	B-PP
B-Cell	1207	1214	stromal	stromal	JJ	B-NP
O	1215	1217	or	or	CC	I-NP
B-Cell	1218	1230	osteoblastic	osteoblastic	JJ	I-NP
I-Cell	1231	1236	cells	cell	NNS	I-NP
O	1237	1244	induced	induce	VBD	B-VP
O	1245	1250	RANKL	RANKL	NN	B-NP
O	1251	1255	mRNA	mRNA	NN	I-NP
O	1256	1266	expression	expression	NN	I-NP
O	1267	1270	and	and	CC	O
O	1271	1280	decreased	decrease	VBD	B-VP
O	1281	1284	OPG	OPG	NN	B-NP
O	1285	1289	mRNA	mRNA	NN	I-NP
O	1290	1300	expression	expression	NN	I-NP
O	1300	1301	.	.	.	O

O	1302	1307	These	These	DT	B-NP
O	1308	1319	experiments	experiment	NNS	I-NP
O	1320	1331	demonstrate	demonstrate	VBP	B-VP
O	1332	1336	that	that	IN	B-SBAR
O	1337	1343	direct	direct	JJ	B-NP
O	1344	1356	interactions	interaction	NNS	I-NP
O	1357	1364	between	between	IN	B-PP
B-Cancer	1365	1371	breast	breast	NN	B-NP
I-Cancer	1372	1378	cancer	cancer	NN	I-NP
O	1379	1382	and	and	CC	O
B-Cell	1383	1390	stromal	stromal	JJ	B-NP
O	1391	1393	or	or	CC	I-NP
B-Cell	1394	1406	osteoblastic	osteoblastic	JJ	I-NP
I-Cell	1407	1412	cells	cell	NNS	I-NP
O	1413	1419	induce	induce	VBP	B-VP
O	1420	1438	osteoclastogenesis	osteoclastogenesis	NN	B-NP
O	1439	1441	in	in	FW	B-ADVP
O	1442	1447	vitro	vitro	FW	I-ADVP
O	1448	1455	through	through	IN	B-PP
O	1456	1466	modulating	modulate	VBG	B-VP
O	1467	1472	RANKL	RANKL	NN	B-NP
O	1473	1483	expression	expression	NN	I-NP
O	1483	1484	.	.	.	O

